SPONSOR
Institut Claudius Regaud
Total Trials
3
Recruiting
3
Phases
Phase 2
Conditions studied: Soft Tissue SarcomaClear Cell SarcomaEpithelioid SarcomaPerivascular Epithelioid Cell NeoplasmsDesmoplastic Small Round Cell TumorMalignant Solitary Fibrous TumorsAlveolar Soft Part SarcomaEpithelioid HemangioendotheliomaLow Grade Fibromyxoid SarcomaSclerosing Epithelioid Fibrosarcoma
Institut Claudius Regaud is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Soft Tissue Sarcoma, Clear Cell Sarcoma, Epithelioid Sarcoma, Perivascular Epithelioid Cell Neoplasms.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Institut Claudius Regaud
How many clinical trials has Institut Claudius Regaud sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Institut Claudius Regaud, of which 3 are actively recruiting participants. These trials cover conditions including Soft Tissue Sarcoma, Clear Cell Sarcoma, Epithelioid Sarcoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Institut Claudius Regaud research focus on?
Institut Claudius Regaud clinical trials span Soft Tissue Sarcoma, Clear Cell Sarcoma, Epithelioid Sarcoma, Perivascular Epithelioid Cell Neoplasms, Desmoplastic Small Round Cell Tumor, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Institut Claudius Regaud clinical trial?
To participate in a Institut Claudius Regaud trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Institut Claudius Regaud trials with current recruitment status updated daily.
Clinical Trials by Institut Claudius Regaud
NCT03967834
Recruiting
Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group
Soft Tissue Sarcoma
NCT04513444 Phase 2
Recruiting
Interest of Medical Hypnosis in Anxious Patients Treated by Radiotherapy
Solid Tumor
NCT06967961
Recruiting
Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers
Urothelial Carcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology